Denmark vs Dominican Republic: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Denmark
0.1%
in 2024
Dominican Republic
0.1%
in 2024
Denmark rank
134th
Dominican Republic rank
134th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Denmark
- Dominican Republic
How they compare
Denmark currently reports 0.1% against 0.1% in Dominican Republic, a difference of 0.0%.
Across all 10 years both countries report, Dominican Republic has been ahead every year.
Denmark ranks 134th and Dominican Republic ranks 134th of 246 countries.
Dominican Republic has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Denmark | Dominican Republic | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.2% | 0.0% | Dominican Republic |
| 2020s | 0.1% | 0.1% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Denmark or Dominican Republic?
- Denmark, at 0.1% against 0.1% in Dominican Republic as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Denmark and Dominican Republic?
- 0.0%, with Denmark ahead.
- How many years of comparable data are there for Denmark and Dominican Republic?
- 10 years are reported by both, from 2015 to 2024.
- How do Denmark and Dominican Republic rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Denmark ranks 134th and Dominican Republic ranks 134th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.